HIV infection and zidovudine use in childbearing women

Pediatrics

Volumn 114, Issue 6, 2004, Pages

  Sia, Jasmine ^a   Paul, Sindy ^b,c   Martin, Rose Marie ^b   Cross, Helene ^b  

^a UNIVERSITY OF MEDICINE AND DENTISTRY OF NEW JERSEY   (United States)

^b NEW JERSEY DEPARTMENT OF HEALTH AND SENIOR SERVICES   (United States)

^c NONE   (United States)

Author keywords

Child health status; Health disparities; HIV; Zidovudine

Indexed keywords

HUMAN IMMUNODEFICIENCY VIRUS ANTIBODY; ZIDOVUDINE; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;

ADULT; AGE DISTRIBUTION; ARTICLE; BLOOD SAMPLING; CAUCASIAN; COMPARATIVE STUDY; CONTROLLED STUDY; DRUG USE; ETHNOLOGY; FEMALE; FILTER; FOOD AND DRUG ADMINISTRATION; HEALTH PROGRAM; HISPANIC; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INBORN ERROR OF METABOLISM; INFECTION RATE; MAJOR CLINICAL STUDY; NEGRO; NEWBORN; PREGNANCY; PRIORITY JOURNAL; RACE; RECORDING; SCREENING; UNITED STATES; VIRUS TRANSMISSION; WESTERN BLOTTING; DISEASE TRANSMISSION; HUMAN IMMUNODEFICIENCY VIRUS PREVALENCE; PREGNANCY COMPLICATION;

ADULT; ANTI-HIV AGENTS; DISEASE TRANSMISSION, VERTICAL; FEMALE; HIV INFECTIONS; HIV SEROPREVALENCE; HUMANS; INFANT, NEWBORN; NEW JERSEY; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; ZIDOVUDINE;

EID: 16644376160     PISSN: 00314005     EISSN: 00314005     Source Type: Journal    
DOI: 10.1542/peds.2004-0414     Document Type: Article

References (21)

1. Connor EM, Sperling RS, Gelber R, et al. Reduction of maternal-infant transmission of HIV-1 with zidovudine treatment. N Engl J Med. 1994;331:1173-1180
2. Fiscus SA, Adimora AA, Schoenbach VJ, et al. Perinatal HIV infection and the effect of zidovudine therapy on transmission in rural and urban counties. JAMA. 1996;275:1483-1488
3. Centers for Disease Control and Prevention. U.S. Public Health Service recommendations for human immunodeficiency virus counseling and voluntary testing for pregnant women. MMWR Recomm Rep. 1995;44:1-15
4. Landesman S, Minkoff H, Holman S, McCalla S, Sijin O. Serosurvey of human immunodeficiency virus infection in parturients. Implications for human immunodeficiency virus testing programs of pregnant women. JAMA. 1987;258:2701-2703
5. Repke JT, Townsend TR, Coberly JS, McQuillan GM, Halsey NA, Quinn TC. Seroprevalence of human immunodeficiency virus type 1 among pregnant women. Am J Perinatol. 1992;9:293-295
6. Mofenson LM and the Committee on Pediatric AIDS. Technical report: perinatal human immunodeficiency virus testing and prevention of transmission. Pediatrics. 2000;106(6). Available at: www.pediatrics.org/cgi/content/full/106/ 6/e88
7. Lindegren, ML. Progress towards elimination of perinatal HIV infection in the United States. Perinatal HIV Prevention Grantee Meeting Summary Plenary Sessions and Workshops; Feb 27-28, 2001; Atlanta, GA. Available at: www.cdc.gov/hiv/PROJECTS/perinatal/materials/meeting-summary.htm
8. Centers for Disease Control and Prevention. HIV prevalence trends in selected populations in the United States: results from national serosurveillance, 1993-1997; 2001. Available at: www.cdc.gov/hiv/pubs/ hivprevalence/hivprevalence.htm
9. New Jersey Department of Health and Senior Services. New Jersey HIV/AIDS Report; Dec 31, 2002. Available at: www.state.nj.us/health/aids/aidsqtr.htm
10. Gwinn M, Pappaioanou M, George JR, et al. Prevalence of HIV infection in childbearing women in the United States. Surveillance using newborn blood samples. JAMA. 1991;265:1704-1708
11. Mei JV, Hannon WH, Dobbs TL, Bell CJ, Spruill C, Gwinn M. Radioimmunoassay for monitoring zidovudine in dried blood spot specimens. Clin Chem. 1998;44:281-286
12. New Jersey Department of Health and Senior Services. Healthy New Jersey 2010. Vol 2. 2001. Available at: http://nj.gov/health/chs/hnj.htm
13. Mofenson LM. Successes and challenges in the perinatal HIV-1 epidemic in the United States as illustrated by the HIV-1 serosurvey of childbearing women [editorial]. Arch Pediatr Adolesc Med. 2004;158:422-425
14. New Jersey Department of Health and Senior Services. New Jersey HIV/AIDS Report December 31, 2003. Available at: http://nj.gov/health/aids/aidsqtr.htm
15. Pulver WP, Glebatis D, Wade N, Birkhead GS, Smith P. Trends from an HIV seroprevalence study among childbearing women in New York State from 1988 through 2000: a valuable epidemiologic tool. Arch Pediatr Adolesc Med. 2004;158:443-448
16. Centers for Disease Control and Prevention. Pregnancy in perinatally HIV-infected adolescents and young adults-Puerto Rico, 2002. MMWR Morb Mortal Wkly Rep. 2003;52:149-151
17. New Jersey Department of Health and Senior Services Division of HIV/AIDS Services. HIV/AIDS epidemiologic profile for the state of New Jersey 2003. Available at: http://nj.gov/health/aids/aidsprv.htm
18. HIV/AIDS Education and Resource Center. Maternal-Child Transmission Perinatal Guidelines. AIDS Info. A service of the US Department of Health and Human Services. Available at: www.aidsinfo.nih.gov/ guidelines/default_db2.asp? id=66
19. Lampe M, Branson B, Paul S, et al. Rapid HIV antibody testing during labor and delivery for women of unknown HIV status: a practical guide and model protocol. Available at: www.cdc.gov/hiv/rapid_testing/materials/ Labor&DeliveryRapid Testing.pdf
20. O'Connor KS, MacDonald SE, Hartling L, et al. The influence of prevalence and policy on the likelihood that a physician will offer HIV screening in pregnancy. Can J Public Health. 2002;93:31-35
21. Centers for Disease Control and Prevention. Success in implementing Public Health Service guidelines to reduce perinatal transmission of HIV-Louisiana, Michigan, New Jersey, and South Carolina, 1993, 1995, and 1996. MMWR Morb Mortal Wkly Rep. 1998;47:688-691